{
  "DOI": "10.1038/s41431-022-01243-2",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01243-2",
  "alternative-id": [
    "1243"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "1 June 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "5 October 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "10 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "28 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 5,
      "value": "9 February 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 6,
      "value": "Update"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "Supplementary table 3 has been corrected."
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 8,
      "value": "16 February 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 9,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 10,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1038/s41431-023-01315-x",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 11,
      "value": "https://doi.org/10.1038/s41431-023-01315-x"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-5994-6253",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Hulshof",
      "given": "Emma C.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Deenen",
      "given": "Maarten J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7476-6867",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nijenhuis",
      "given": "Marga",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Soree",
      "given": "Bianca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Boer-Veger",
      "given": "Nienke J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buunk",
      "given": "Anne-Marie",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9927-7266",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Houwink",
      "given": "Elisa J. F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Risselada",
      "given": "Arne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rongen",
      "given": "Gerard A. P. J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Schaik",
      "given": "Ron H. N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1429-4789",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Touw",
      "given": "Daan J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Weide",
      "given": "Jan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2298-9924",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van Westrhenen",
      "given": "Roos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deneer",
      "given": "Vera H. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3965-5552",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        11,
        28
      ]
    ],
    "date-time": "2022-11-28T08:04:35Z",
    "timestamp": 1669622675000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        1
      ]
    ],
    "date-time": "2023-09-01T23:03:40Z",
    "timestamp": 1693609420000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        23
      ]
    ],
    "date-time": "2024-04-23T11:25:44Z",
    "timestamp": 1713871544718
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2022,
        11,
        28
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2023,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            11,
            28
          ]
        ],
        "date-time": "2022-11-28T00:00:00Z",
        "timestamp": 1669593600000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            11,
            28
          ]
        ],
        "date-time": "2022-11-28T00:00:00Z",
        "timestamp": 1669593600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01243-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01243-2",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01243-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "982-987",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        11,
        28
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        11,
        28
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/sj.clpt.6100507.",
      "author": "J Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharm Ther",
      "key": "1243_CR1",
      "unstructured": "Swen J, Wilting I, Goede A, de, Grandia L, Mulder H, Touw D, et al. Pharmacogenetics: From Bench to Byte. Clin Pharm Ther. 2008;83:781–7. https://doi.org/10.1038/sj.clpt.6100507.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41431-018-0205-4",
      "author": "H-J Guchelaar",
      "doi-asserted-by": "publisher",
      "first-page": "1399",
      "journal-title": "Eur J Hum Genet",
      "key": "1243_CR2",
      "unstructured": "Guchelaar H-J. Pharmacogenomics, a novel section in the European Journal of Human Genetics. Eur J Hum Genet. 2018;26:1399–400. https://doi.org/10.1038/s41431-018-0205-4.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-019-0540-0",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Eur J Hum Genet",
      "key": "1243_CR3",
      "unstructured": "Lunenburg CATC, van der Wouden CH, Nijenhuis M, Crommentuijn-van Rhenen MH, de Boer-Veger NJ, Buunk AM, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines. Eur J Hum Genet. 2020;28:508–17. https://doi.org/10.1038/s41431-019-0540-0.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-021-00920-y",
      "doi-asserted-by": "publisher",
      "key": "1243_CR4",
      "unstructured": "Matic M, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk A-M, Houwink EJF, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Hum Genet. 2021. https://doi.org/10.1038/s41431-021-00920-y."
    },
    {
      "DOI": "10.1038/s41431-021-01004-7",
      "doi-asserted-by": "publisher",
      "key": "1243_CR5",
      "unstructured": "Brouwer JMJL, Nijenhuis M, Soree B, Guchelaar H-J, Swen JJ, van Schaik RHN, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. Eur J Hum Genet. 2021. https://doi.org/10.1038/s41431-021-01004-7."
    },
    {
      "author": "P Rougier",
      "first-page": "34",
      "journal-title": "Semin Oncol",
      "key": "1243_CR6",
      "unstructured": "Rougier P, Bugat R. CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile. Semin Oncol. 1996;23:34–41.",
      "volume": "23",
      "year": "1996"
    },
    {
      "author": "ML Rothenberg",
      "first-page": "39",
      "journal-title": "Semin Oncol",
      "key": "1243_CR7",
      "unstructured": "Rothenberg ML. Efficacy and toxicity of irinotecan in patients with colorectal cancer. Semin Oncol. 1998;25:39–46.",
      "volume": "25",
      "year": "1998"
    },
    {
      "DOI": "10.1056/nejm199511023331802.",
      "author": "PJ Bosma",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "N. Engl J Med",
      "key": "1243_CR8",
      "unstructured": "Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s Syndrome. N. Engl J Med. 1995;333:1171–5. https://doi.org/10.1056/nejm199511023331802.",
      "volume": "333",
      "year": "1995"
    },
    {
      "key": "1243_CR9",
      "unstructured": "UGT1A1 allele nomenclature n.d. https://www.pharmacogenomics.pha.ulaval.ca/wp-content/uploads/2015/04/UGT1A1-allele-nomenclature.html (accessed September 6, 2021)."
    },
    {
      "DOI": "10.1101/531210",
      "doi-asserted-by": "publisher",
      "key": "1243_CR10",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv. 2019:531210. https://doi.org/10.1101/531210."
    },
    {
      "DOI": "10.1093/annonc/mdn645.",
      "author": "Y Akiyama",
      "doi-asserted-by": "publisher",
      "first-page": "2089",
      "journal-title": "Ann Oncol",
      "key": "1243_CR11",
      "unstructured": "Akiyama Y, Fujita K, Nagashima F, Yamamoto W, Endo H, Sunakawa Y, et al. Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy. Ann Oncol. 2008;19:2089–90. https://doi.org/10.1093/annonc/mdn645.",
      "volume": "19",
      "year": "2008"
    },
    {
      "author": "LK Teh",
      "first-page": "249",
      "journal-title": "Indian J Med Res",
      "key": "1243_CR12",
      "unstructured": "Teh LK, Hashim H, Zakaria ZA, Salleh MZ. Polymorphisms of UGT1A1*6, UGT1A1*27 \u0026 UGT1A1*28 in three major ethnic groups from Malaysia. Indian J Med Res. 2012;136:249–59.",
      "volume": "136",
      "year": "2012"
    },
    {
      "DOI": "10.2165/11594440-000000000-00000.",
      "author": "C Sung",
      "doi-asserted-by": "publisher",
      "first-page": "1167",
      "journal-title": "Drug Saf",
      "key": "1243_CR13",
      "unstructured": "Sung C, Lee PL, Tan LL, Toh DSL. Pharmacogenetic risk for adverse reactions to irinotecan in the major ethnic populations of Singapore. Drug Saf. 2011;34:1167–75. https://doi.org/10.2165/11594440-000000000-00000.",
      "volume": "34",
      "year": "2011"
    },
    {
      "DOI": "10.1080/15216549800203512.",
      "author": "K Akaba",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "journal-title": "Biochem Mol Biol Int",
      "key": "1243_CR14",
      "unstructured": "Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int. 1998;46:21–6. https://doi.org/10.1080/15216549800203512.",
      "volume": "46",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s40262-018-0644-7.",
      "author": "FM de Man",
      "doi-asserted-by": "publisher",
      "first-page": "1229",
      "journal-title": "Clin Pharmacokinet",
      "key": "1243_CR15",
      "unstructured": "de Man FM, Goey AKL, van Schaik RHN, Mathijssen RHJ, Bins S. Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics. Clin Pharmacokinet. 2018;57:1229–54. https://doi.org/10.1007/s40262-018-0644-7.",
      "volume": "57",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10637-013-0034-9.",
      "author": "MP Goetz",
      "doi-asserted-by": "publisher",
      "first-page": "1559",
      "journal-title": "Invest N. Drugs",
      "key": "1243_CR16",
      "unstructured": "Goetz MP, McKean HA, Reid JM, Mandrekar SJ, Tan AD, Kuffel MA, et al. UGT1A1 genotype-guided phase i study of irinotecan, oxaliplatin, and capecitabine. Invest N. Drugs. 2013;31:1559–67. https://doi.org/10.1007/s10637-013-0034-9.",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00280-009-1008-7.",
      "author": "CS Denlinger",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Cancer Chemother Pharm",
      "key": "1243_CR17",
      "unstructured": "Denlinger CS, Blanchard R, Xu L, Bernaards C, Litwin S, Spittle C, et al. Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors. Cancer Chemother Pharm. 2009;65:97–105. https://doi.org/10.1007/s00280-009-1008-7.",
      "volume": "65",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.tpj.6500072.",
      "author": "L Iyer",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "Pharmacogenomics J",
      "key": "1243_CR18",
      "unstructured": "Iyer L, Das S, Janisch L, Wen M, Ramírez J, Karrison T, et al. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J. 2002;2:43–7. https://doi.org/10.1038/sj.tpj.6500072.",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1634/theoncologist.11-8-944.",
      "author": "FA de Jong",
      "doi-asserted-by": "publisher",
      "first-page": "944",
      "journal-title": "Oncologist",
      "key": "1243_CR19",
      "unstructured": "de Jong FA, Kehrer DFS, Mathijssen RHJ, Creemers G, de Bruijn P, van Schaik RHN, et al. Prophylaxis of irinotecan‐induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double‐blind, randomized, placebo‐controlled study. Oncologist. 2006;11:944–54. https://doi.org/10.1634/theoncologist.11-8-944.",
      "volume": "11",
      "year": "2006"
    },
    {
      "DOI": "10.1177/0091270004267159.",
      "author": "L Paoluzzi",
      "doi-asserted-by": "publisher",
      "first-page": "854",
      "journal-title": "J Clin Pharm",
      "key": "1243_CR20",
      "unstructured": "Paoluzzi L, Singh AS, Price DK, Danesi R, Mathijssen RHJ, Verweij J, et al. Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. J Clin Pharm. 2004;44:854–60. https://doi.org/10.1177/0091270004267159.",
      "volume": "44",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2004.07.173.",
      "author": "F Innocenti",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "journal-title": "J Clin Oncol",
      "key": "1243_CR21",
      "unstructured": "Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol. 2004;22:1382–8. https://doi.org/10.1200/JCO.2004.07.173.",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1016/J.EJCA.2021.12.009.",
      "author": "EC Hulshof",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "journal-title": "Eur J Cancer",
      "key": "1243_CR22",
      "unstructured": "Hulshof EC, de With M, de Man FM, Creemers GJ, Deiman BALM, Swen JJ, et al. UGT1A1 genotype-guided dosing of irinotecan: a prospective safety and cost analysis in poor metaboliser patients. Eur J Cancer. 2022;162:148–57. https://doi.org/10.1016/J.EJCA.2021.12.009.",
      "volume": "162",
      "year": "2022"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-10-1122.",
      "author": "ZY Hu",
      "doi-asserted-by": "publisher",
      "first-page": "3832",
      "journal-title": "Clin Cancer Res",
      "key": "1243_CR23",
      "unstructured": "Hu ZY, Yu Q, Pei Q, Guo C. Dose-dependent association between UGT1A1*28 genotype and irinotecan-induced neutropenia: Low doses also increase risk. Clin Cancer Res. 2010;16:3832–42. https://doi.org/10.1158/1078-0432.CCR-10-1122.",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1038/tpj.2013.10.",
      "author": "X Liu",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "journal-title": "Pharmacogenomics J",
      "key": "1243_CR24",
      "unstructured": "Liu X, Cheng D, Kuang Q, Liu G, Xu W. Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. Pharmacogenomics J. 2014;14:120–9. https://doi.org/10.1038/tpj.2013.10.",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.tranon.2015.11.002.",
      "author": "CY Lu",
      "doi-asserted-by": "publisher",
      "first-page": "474",
      "journal-title": "Transl Oncol",
      "key": "1243_CR25",
      "unstructured": "Lu CY, Huang CW, Wu IC, Tsai HL, Ma CJ, Yeh YS, et al. Clinical implication of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab combined with FOLFIRI in the first-line setting. Transl Oncol. 2015;8:474–9. https://doi.org/10.1016/j.tranon.2015.11.002.",
      "volume": "8",
      "year": "2015"
    },
    {
      "DOI": "10.1097/FPC.0b013e328014341f.",
      "author": "H Minami",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "journal-title": "Pharmacogenet Genomics",
      "key": "1243_CR26",
      "unstructured": "Minami H, Sai K, Saeki M, Saito Y, Ozawa S, Suzuki K, et al. Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenet Genomics. 2007;17:497–504. https://doi.org/10.1097/FPC.0b013e328014341f.",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrd3921",
      "doi-asserted-by": "publisher",
      "key": "1243_CR27",
      "unstructured": "Pirmohamed M, Hughes DA. Pharmacogenetic tests: the need for a level playing field. Nat Rev Drug Discov. 2013;12:3–4. https://doi.org/10.1038/nrd3921."
    },
    {
      "DOI": "10.1371/journal.pmed.0040209.",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "e209",
      "journal-title": "PLoS Med",
      "key": "1243_CR28",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H, de Vries EGE, Assendelft WJJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209. https://doi.org/10.1371/journal.pmed.0040209.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1002/cpt.1049.",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Clin Pharm Ther",
      "key": "1243_CR29",
      "unstructured": "Swen JJ, Nijenhuis M, van Rhenen M, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic information in clinical guidelines: The European perspective. Clin Pharm Ther. 2018;103:795–801. https://doi.org/10.1002/cpt.1049.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1111/fcp.12117.",
      "author": "MC Etienne-Grimaldi",
      "doi-asserted-by": "publisher",
      "first-page": "219",
      "journal-title": "Fundam Clin Pharm",
      "key": "1243_CR30",
      "unstructured": "Etienne-Grimaldi MC, Boyer JC, Thomas F, Quaranta S, Picard N, Loriot MA, et al. UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundam Clin Pharm. 2015;29:219–37. https://doi.org/10.1111/fcp.12117.",
      "volume": "29",
      "year": "2015"
    },
    {
      "key": "1243_CR31",
      "unstructured": "AIOM - SIF. Raccomandazioni par analisi farmacogenetiche n.d. https://www.aiom.it/raccomandazioni-2019-per-analisi-farmacogenetiche/ (accessed November 15, 2021)."
    },
    {
      "key": "1243_CR32",
      "unstructured": "Stanford University \u0026 St. Jude Children’s Research Hospital. Clinical Pharmacogenetics Implementation Consortium. PharmGKB PGRN 2020. https://cpicpgx.org/ (accessed May 8, 2020)."
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01243-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "31"
}